Connected operations vendor Samsara also announced a new ‘privacy mode’ for drivers in vehicles, following feedback from ...

Aerovate Therapeutics (AVTE) and Jade Biosciences announced that they have entered into a definitive merger agreement for an all-stock ...

Logos Capital, Deerfield Management, OrbiMed, and Samsara BioCapital, among other leading investment management firms. The financing includes common stock and pre-funded warrants to purchase ...

Tom Frohlich, currently CEO of Jade, will lead the combined company, which will be advised by a board of directors that includes representatives from Samsara BioCapital, Oruka Therapeutics and ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Oct. 30, 2024 /PRNewswire/ -- Mission BioCapital (MBC) announced today the first eight investments supported by the Platinum Program, a competitive process managed by MBC to accelerate the launch ...

Dr. Baffi, a Venture Partner at Samsara BioCapital, LLC, said: “Individuals living with the devastating effects of ALS urgently need more treatment options that improve their quality of life and ...

As you can see from the chart above the percentage of shares that are sold short for Samsara has declined since its last report. This does not mean that the stock is going to rise in the near-term ...

and Samsara BioCapital. Concurrent with the funding, Shelley Chu, head of Lightspeed Venture Partners' healthcare team, and Evan Rachlin, cofounder and managing partner of Ascenta Capital, will join ...